Innovita is a leading manufacturer of diagnostic solutions for respiratory pathogens diagnosis with a global customer base.
The clinical auxiliary diagnosis of 2019-nCoV requires simple, economical and feasible methods. The human immunesystem can produce specific lgM and lgG antibodies after virus infection . lgM is the earliest antibody that appears upon the first immune response. The detection of lgM antibody indicates a recent infection and can be used as auxiliary diagnosis of early infection. lgG is produced later and lasts long, which can be used as an indicator of previous or secondary infection.
The kit is intended for the qualitative detection of lgM and lgG antibodies against 2019 Novel Coronavirus (2019-nCoV) in human serum/plasma/ venous whole blood specimen and for the auxiliary diagnosis of 2019-nCoV infection. The confirmation or exclusion of infection helps to quickly identify those who need to self isolate whether it be amongst your staff or prospective patients.
The tester can conclude the following depending on the result within 15 minutes.
Reviews
There are no reviews yet.